September 9, 2021

The Food Allergy Collaborative is currently preparing for a Externally-led Patient-Focused Drug Development (PFDD) meeting in September, 2021, which will provide a platform for food allergic patients to inform the FDA in understanding of the therapeutic context for drug development and evaluation in food allergy.


We are no longer accepting submissions to present an in-person testimony as a patient panelist at the Patient Focus Drug Development (PFDD) meeting. Please register here to attend the meeting virtually and submit written comments during the live event.

*Barring any local, state or national restrictions related to COVID-19. Please note, the Food Allergy Collaborative will adhere to all CDC recommendations for group gatherings, as well as state and local restrictions for social distancing and mask-wearing.